Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Survivin, versatile modulation of cell division and apoptosis in cancer

Abstract

Survivin is a member of the inhibitor of apoptosis (IAP) gene family that has attracted attention from several viewpoints of basic and translational research. Its cell cycle-regulated expression at mitosis and association with the mitotic apparatus have been of interest to cell biologists studying faithful segregation of sister chromatids and timely separation of daughter cells. Investigators interested in mechanisms of apoptosis have found survivin an evolving challenge: while survivin inhibits apoptosis in vitro and in vivo, this pathway may be more selective as compared to cytoprotection mediated by other IAPs. Finally, basic and translational researchers in cancer biology have converged on survivin as a pivotal cancer gene, not simply for its sharp expression in tumors and not in normal tissues, but also for the potential exploitation of this pathway in cancer diagnosis and therapy. The objective of the present contribution is to line up current evidence and emerging concepts on the multifaceted functions of survivin in cell death and cell division, and how this pathway is being pursued for novel cancer therapeutic strategies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Adams RR, Carmena M and Earnshaw WC . (2001). Trends Cell Biol., 11, 49–54.

  • Adida C, Berrebi D, Peuchmaur M, Reyes-Mugica M and Altieri DC . (1998a). Lancet, 351, 882–883.

  • Adida C, Crotty PL, McGrath J, Berrebi D, Diebold J and Altieri DC . (1998b). Am. J. Pathol., 152, 43–49.

  • Adida C, Haioun C, Gaulard P, Lepage E, Morel P, Briere J, Dombret H, Reyes F, Diebold J, Gisselbrecht C, Salles G, Altieri DC and Molina TJ . (2000a). Blood, 96, 1921–1925.

  • Adida C, Recher C, Raffoux E, Daniel MT, Taksin AL, Rousselot P, Sigaux F, Degos L, Altieri DC and Dombret H . (2000b). Br. J. Haematol., 111, 196–203.

  • Allen SM, Florell SR, Hanks AN, Alexander A, Diedrich MJ, Altieri DC and Grossman D . (2003). Cancer Res., 63, 567–572.

  • Altieri DC . (2003). Nat. Rev. Cancer, 3, 46–54.

  • Ambrosini G, Adida C and Altieri DC . (1997). Nat. Med., 3, 917–921.

  • Andersen MH, Pedersen LO, Becker JC and Straten PT . (2001). Cancer Res., 61, 869–872.

  • Andersen MH and Thor SP . (2002). Histol. Histopathol., 17, 669–675.

  • Aoki Y, Feldman GM and Tosato G . (2003). Blood, 101, 1535–1542.

  • Badie C, Itzhaki JE, Sullivan MJ, Carpenter AJ and Porter AC . (2000). Mol. Cell. Biol., 20, 2358–2366.

  • Badran A, Yoshida A, Wano Y, Mutoh M, Imamura S, Yamashita T, Tsutani H, Inuzuka M and Ueda T . (2003). Int. J. Oncol., 22, 59–64.

  • Banks DP, Plescia J, Altieri DC, Chen J, Rosenberg SH, Zhang H and Ng SC . (2000). Blood, 96, 4002–4003.

  • Bao R, Connolly DC, Murphy M, Green J, Weinstein JK, Pisarcik DA and Hamilton TC . (2002). J. Natl. Cancer Inst., 94, 522–528.

  • Bolton MA, Lan W, Powers SE, McCleland ML, Kuang J and Stukenberg PT . (2002). Mol. Biol. Cell, 13, 3064–3077.

  • Carter BZ, Milella M, Altieri DC and Andreeff M . (2001). Blood, 97, 2784–2790.

  • Chakravarti A, Noll E, Black PM, Finkelstein DF, Finkelstein DM, Dyson NJ and Loeffler JS . (2002). J. Clin. Oncol., 20, 1063–1068.

  • Chantalat L, Skoufias DA, Kleman JP, Jung B, Dideberg O and Margolis RL . (2000). Mol. Cell, 6, 183–189.

  • Chen J, Jin S, Tahir SK, Zhang H, Liu X, Sarthy AV, McGonigal TP, Liu Z, Rosenberg SH and Ng SC . (2003). J. Biol. Chem., 278, 486–490.

  • Chen J, Wu W, Tahir SK, Kroeger PE, Rosenberg SH, Cowsert LM, Bennett F, Krajewski S, Krajewska M, Welsh K, Reed JC and Ng SC . (2000). Neoplasia, 2, 235–241.

  • Choi KS, Lee TH and Jung MH . (2003). Cancer Gene Ther., 10, 87–95.

  • Conway EM, Pollefeyt S, Cornelissen J, DeBaere I, Steiner-Mosonyi M, Ong K, Baens M, Collen D and Schuh AC . (2000). Blood, 95, 1435–1442.

  • Conway EM, Pollefeyt S, Steiner-Mosonyi M, Luo W, Devriese A, Lupu F, Bono F, Leducq N, Dol F, Schaeffer P, Collen D and Herbert JM . (2002). Gastroenterology, 123, 619–631.

  • Datta SR, Brunet A and Greenberg ME . (1999). Genes Dev., 13, 2905–2927.

  • Du C, Fang M, Li Y, Li L and Wang X . (2000). Cell, 102, 33–42.

  • Evan GI and Vousden KH . (2001). Nature, 411, 342–348.

  • Fortugno P, Wall NR, Giodini A, O'Connor DS, Plescia J, Padgett KM, Tognin S, Marchisio PC and Altieri DC . (2002). J. Cell Sci., 115, 575–585.

  • Fraser AG, James C, Evan GI and Hengartner MO . (1999). Curr. Biol., 9, 292–301.

  • Fukuda S, Foster RG, Porter SB and Pelus LM . (2002). Blood, 100, 2463–2471.

  • Fukuda S and Pelus LM . (2001). Blood, 98, 2091–2100.

  • Garcia JF, Camacho FI, Morente M, Fraga M, Montalban C, Alvaro T, Bellas C, Castano A, Diez A, Flores T, Martin C, Martinez MA, Mazorra F, Menarguez J, Mestre MJ, Mollejo M, Saez AI, Sanchez L and Piris MA . (2003). Blood, 101, 681–689.

  • Gianani R, Jarboe E, Orlicky D, Frost M, Bobak J, Lehner R and Shroyer KR . (2001). Hum. Pathol., 32, 119–125.

  • Giodini A, Kallio M, Wall NR, Gorbsky GJ, Tognin S, Marchisio PC, Symons M and Altieri DC . (2002). Cancer Res., 62, 2462–2467.

  • Grabowski P, Kuhnel T, Muhr-Wilkenshoff F, Heine B, Stein H, Hopfner M, Germer CT and Scherubl H . (2003). Br. J. Cancer, 88, 115–119.

  • Gradilone A, Gazzaniga P, Ribuffo D, Scarpa S, Cigna E, Vasaturo F, Bottoni U, Innocenzi D, Calvieri S, Scuderi N, Frati L and Agliano AM . (2003). J. Clin. Oncol., 21, 306–312.

  • Gray NS, Wodicka L, Thunnissen AM, Norman TC, Kwon S, Espinoza FH, Morgan DO, Barnes G, LeClerc S, Meijer L, Kim SH, Lockhart DJ and Schultz PG . (1998). Science, 281, 533–538.

  • Grossman D, Kim PJ, Blanc-Brude OP, Brash DE, Tognin S, Marchisio PC and Altieri DC . (2001a). J. Clin. Invest., 108, 991–999.

  • Grossman D, Kim PJ, Schechner JS and Altieri DC . (2001b). Proc. Natl. Acad. Sci. USA, 98, 635–640.

  • Grossman D, McNiff JM, Li F and Altieri DC . (1999). J. Invest. Dermatol., 113, 1076–1081.

  • Hanahan D and Weinberg RA . (2000). Cell, 100, 57–70.

  • Harfouche R, Hassessian HM, Guo Y, Faivre V, Srikant CB, Yancopoulos GD and Hussain SN . (2002). Microvasc. Res., 64, 135–147.

  • Hattori M, Sakamoto H, Satoh K and Yamamoto T . (2001). Cancer Lett., 169, 155–164.

  • Hausladen DA, Wheeler MA, Altieri DC, Colberg JW and Weiss RM . (2003). J. Urol, 170, 230–234.

  • Hirohashi Y, Torigoe T, Maeda A, Nabeta Y, Kamiguchi K, Sato T, Yoda J, Ikeda H, Hirata K, Yamanaka N and Sato N . (2002). Clin. Cancer Res., 8, 1731–1739.

  • Hoffman WH, Biade S, Zilfou JT, Chen J and Murphy M . (2001). J. Biol. Chem., 277, 3247–3257.

  • Ikeguchi M and Kaibara N . (2002). Br. J. Cancer, 87, 883–887.

  • Ikeguchi M, Ueta T, Yamane Y, Hirooka Y and Kaibara N . (2002). Clin. Cancer Res., 8, 3131–3136.

  • Islam A, Kageyama H, Takada N, Kawamoto T, Takayasu H, Isogai E, Ohira M, Hashizume K, Kobayashi H, Kaneko Y and Nakagawara A . (2000). Oncogene, 19, 617–623.

  • Jiang X, Wilford C, Duensing S, Munger K, Jones G and Jones D . (2001). J. Cell. Biochem., 83, 342–354.

  • Jones G, Jones D, Zhou L, Steller H and Chu Y . (2000). J. Biol. Chem., 275, 22157–22165.

  • Kajiwara Y, Yamasaki F, Hama S, Yahara K, Yoshioka H, Sugiyama K, Arita K and Kurisu K . (2003). Cancer, 97, 1077–1083.

  • Kallio MJ, Nieminen M and Eriksson JE . (2001). FASEB J., 15, 2721–2723.

  • Kamihira S, Yamada Y, Hirakata Y, Tomonaga M, Sugahara K, Hayashi T, Dateki N, Harasawa H and Nakayama K . (2001). Br. J. Haematol., 114, 63–69.

  • Kanwar JR, Shen WP, Kanwar RK, Berg RW and Krissansen GW . (2001). J. Natl. Cancer Inst., 93, 1541–1552.

  • Kappler M, Kohler T, Kampf C, Diestelkotter P, Wurl P, Schmitz M, Bartel F, Lautenschlager C, Rieber EP, Schmidt H, Bache M, Taubert H and Meye A . (2001). Int. J. Cancer, 95, 360–363.

  • Kasof GM and Gomes BC . (2000). J. Biol. Chem., 276, 3238–3246.

  • Kato J, Kuwabara Y, Mitani M, Shinoda N, Sato A, Toyama T, Mitsui A, Nishiwaki T, Moriyama S, Kudo J and Fujii Y . (2001). Int. J. Cancer, 95, 92–95.

  • Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T and Tanigawa N . (1998). Cancer Res., 58, 5071–5074.

  • Khuri F, Nemunaitis J, Ganly I, Arsenau J, Tannock IF, Romel L, Gore M, Ironside J, MacDougall RH, Heise C, Randlev B, Gillenwater AM, Bruso P, Kaye SB, Hong WK and Kirn D . (2000). Nat. Med., 6, 879–995.

  • Kobayashi K, Hatano M, Otaki M, Ogasawara T and Tokuhisa T . (1999). Proc. Natl. Acad. Sci. USA, 96, 1457–1462.

  • Koch CA, Vortmeyer AO, Diallo R, Poremba C, Giordano TJ, Sanders D, Bornstein SR, Chrousos GP and Pacak K . (2002). Eur. J. Endocrinol., 146, 381–388.

  • Kuttler F, Valnet-Rabier MB, Angonin R, Ferrand C, Deconinck E, Mougin C, Cahn JY and Fest T . (2002). Leukemia, 16, 726–735.

  • Li F, Ackermann EJ, Bennett CF, Rothermel AL, Plescia J, Tognin S, Villa A, Marchisio PC and Altieri DC . (1999). Nat. Cell Biol., 1, 461–466.

  • Li F and Altieri DC . (1999a). Cancer Res., 59, 3143–3151.

  • Li F and Altieri DC . (1999b). Biochem. J., 344 (Part 2), 305–311.

  • Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC and Altieri DC . (1998). Nature, 396, 580–584.

  • Lu CD, Altieri DC and Tanigawa N . (1998). Cancer Res., 58, 1808–1812.

  • Mahboubi K, Li F, Plescia J, Kirkiles-Smith NC, Mesri M, Du Y, Carroll JM, Elias JA, Altieri DC and Pober JS . (2001). Lab. Invest., 81, 327–334.

  • Mahotka C, Liebmann J, Wenzel M, Suschek CV, Schmitt M, Gabbert HE and Gerharz CD . (2002). Cell Death Differ., 9, 1334–1342.

  • Mahotka C, Wenzel M, Springer E, Gabbert HE and Gerharz CD . (1999). Cancer Res., 59, 6097–6102.

  • Mesri M, Morales-Ruiz M, Ackermann EJ, Bennett CF, Pober JS, Sessa WC and Altieri DC . (2001a). Am. J. Pathol., 158, 1757–1765.

  • Mesri M, Wall NR, Li J, Kim RW and Altieri DC . (2001b). J. Clin. Invest., 108, 981–990.

  • Mirza A, McGuirk M, Hockenberry TN, Wu Q, Ashar H, Black S, Wen SF, Wang L, Kirschmeier P, Bishop WR, Nielsen LL, Pickett CB and Liu S . (2002). Oncogene, 21, 2613–2622.

  • Monzo M, Rosell R, Felip E, Astudillo J, Sanchez JJ, Maestre J, Martin C, Font A, Barnadas A and Abad A . (1999). J. Clin. Oncol., 17, 2100–2104.

  • Muchmore SW, Chen J, Jakob C, Zakula D, Matayoshi ED, Wu W, Zhang H, Li F, Ng SC and Altieri DC . (2000). Mol. Cell, 6, 173–182.

  • Murphy CR, Sabel JL, Sandler AD and Dagle JM . (2002). Dev. Dyn., 225, 597–601.

  • O'Connor DS, Grossman D, Plescia J, Li F, Zhang H, Villa A, Tognin S, Marchisio PC and Altieri DC . (2000a). Proc. Natl. Acad. Sci. USA, 97, 13103–13107.

  • O'Connor DS, Schechner JS, Adida C, Mesri M, Rothermel AL, Li F, Nath AK, Pober JS and Altieri DC . (2000b). Am. J. Pathol., 156, 393–398.

  • O'Connor DS, Wall NR, Porter AC and Altieri DC . (2002). Cancer Cell, 2, 43–54.

  • Olie RA, Simoes-Wust AP, Baumann B, Leech SH, Fabbro D, Stahel RA and Zangemeister-Wittke U . (2000). Cancer Res., 60, 2805–2809.

  • Ota T, Suto S, Katayama H, Han ZB, Suzuki F, Maeda M, Tanino M, Terada Y and Tatsuka M . (2002). Cancer Res., 62, 5168–5177.

  • Papapetropoulos A, Fulton D, Mahboubi K, Kalb RG, O'Connor DS, Li F, Altieri DC and Sessa WC . (2000). J. Biol. Chem., 275, 9102–9105.

  • Pennati M, Binda M, Colella G, Folini M, Citti L, Villa R, Daidone MG and Zaffaroni N . (2003). J. Invest. Dermatol., 120, 648–654.

  • Rodriguez JA, Span SW, Ferreira CG, Kruyt FA and Giaccone G . (2002). Exp. Cell Res., 275, 44–53.

  • Rohayem J, Diestelkoetter P, Weigle B, Oehmichen A, Schmitz M, Mehlhorn J, Conrad K and Rieber EP . (2000). Cancer Res., 60, 1815–1817.

  • Saitoh Y, Yaginuma Y and Ishikawa M . (1999). Int. J. Oncol., 15, 137–141.

  • Salvesen GS and Duckett CS . (2002). Nat. Rev. Mol. Cell Biol., 3, 401–410.

  • Sarela AI, Macadam RC, Farmery SM, Markham AF and Guillou PJ . (2000). Gut, 46, 645–650.

  • Satoh K, Kaneko K, Hirota M, Masamune A, Satoh A and Shimosegawa T . (2001). Cancer, 92, 271–278.

  • Sausville EA . (2002). Trends Mol. Med., 8, S32–S37.

  • Schmidt SM, Schag K, Mueller MR, Weck MM, Appel S, Kanz L, Gruenebach F and Brossart P . (2003). Blood, 102, 571–576.

  • Schmitz M, Diestelkoetter P, Weigle B, Schmachtenberg F, Stevanovic S, Ockert D, Rammensee HG and Rieber EP . (2000). Cancer Res., 60, 4845–4849.

  • Schwartz GK, O'Reilly E, Ilson D, Saltz L, Sharma S, Tong W, Maslak P, Stoltz M, Eden L, Perkins P, Endres S, Barazzoul J, Spriggs D and Kelsen D . (2002). J. Clin. Oncol., 20, 2157–2170.

  • Shankar SL, Mani S, O'Guin KN, Kandimalla ER, Agrawal S and Shafit-Zagardo B . (2001). J. Neurochem., 79, 426–436.

  • Shannon JB and Salmon ED . (2002). Curr. Biol., 12, R458–R460.

  • Shen Y, Devgan G, Darnell Jr JE and Bromberg JF . (2001). Proc. Natl. Acad. Sci. USA, 98, 1543–1548.

  • Shi Y . (2002). Mol. Cell, 9, 459–470.

  • Shin S, Sung BJ, Cho YS, Kim HJ, Ha NC, Hwang JI, Chung CW, Jung YK and Oh BH . (2001). Biochemistry, 40, 1117–1123.

  • Silke J and Vaux DL . (2001). J. Cell Sci., 114, 1821–1827.

  • Skoufias DA, Mollinari C, Lacroix FB and Margolis RL . (2000). J. Cell Biol., 151, 1575–1582.

  • Song Z, Yao X and Wu M . (2003). J. Biol. Chem..

  • Speliotes EK, Uren A, Vaux D and Horvitz HR . (2000). Mol. Cell, 6, 211–223.

  • Suzuki A, Ito T, Kawano H, Hayashida M, Hayasaki Y, Tsutomi Y, Akahane K, Nakano T, Miura M and Shiraki K . (2000). Oncogene, 19, 1346–1353.

  • Swana HS, Grossman D, Anthony JN, Weiss RM and Altieri DC . (1999). N. Engl. J. Med., 341, 452–453.

  • Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T and Reed JC . (1998). Cancer Res., 58, 5315–5320.

  • Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M and Tanigawa N . (2000). Clin. Cancer Res., 6, 127–134.

  • Tran J, Master Z, Yu JL, Rak J, Dumont DJ and Kerbel RS . (2002). Proc. Natl. Acad. Sci. USA, 99, 4349–4354.

  • Tran J, Rak J, Sheehan C, Saibil SD, LaCasse E, Korneluk RG and Kerbel RS . (1999). Biochem. Biophys. Res. Commun., 264, 781–788.

  • Turkson J and Jove R . (2000). Oncogene, 19, 6613–6626.

  • Uren AG, Beilharz T, O'Connell MJ, Bugg SJ, van Driel R, Vaux DL and Lithgow T . (1999). Proc. Natl. Acad. Sci. USA, 96, 10170–10175.

  • Uren AG, Wong L, Pakusch M, Fowler KJ, Burrows FJ, Vaux DL and Choo KH . (2000). Curr. Biol., 10, 1319–1328.

  • van de Wetering M, Sancho E, Vervweij C, de Lau I, Hurlstone A, van der Horn K, Batlle E, Coudreuse D, Haramis A-P, van den Born M, Soete G, Pals S, Eilers M, Medema R and Clevers H . (2002). Cell, 111, 241–250.

  • van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R and Friend SH . (2002). Nature, 415, 530–536.

  • Velculescu VE, Madden SL, Zhang L, Lash AE, Yu J, Rago C, Lal A, Wang CJ, Beaudry GA, Ciriello KM, Cook BP, Dufault MR, Ferguson AT, Gao Y, He TC, Hermeking H, Hiraldo SK, Hwang PM, Lopez MA, Luderer HF, Mathews B, Petroziello JM, Polyak K, Zawel L, Zhang W, Zhang X, Zhou W, Haluska FG, Jen J, Sukumar S, Landes GM, Riggins GJ, Vogelstein B and Kinzler KW . (1999). Nat. Genet., 23, 387–388.

  • Verdecia MA, Huang H, Dutil E, Kaiser DA, Hunter T and Noel JP . (2000). Nat. Struct. Biol., 7, 602–608.

  • Wall NR, O'Connor DS, Plescia J, Pommier Y and Altieri DC . (2003). Cancer Res., 63, 230–235.

  • Wang HW, Sharp TV, Koumi A, Koentges G and Boshoff C . (2002). EMBO J., 21, 2602–2615.

  • Wang X . (2001). Genes Dev., 15, 2922–2933.

  • Wheatley SP, Carvalho A, Vagnarelli P and Earnshaw WC . (2001). Curr. Biol., 11, 886–890.

  • Williams NS, Gaynor RB, Scoggin S, Verma U, Gokaslan T, Simmang C, Fleming J, Tavana D, Frenkel E and Becerra C . (2003). Clin. Cancer Res., 9, 931–946.

  • Wurl P, Kappler M, Meye A, Bartel F, Kohler T, Lautenschlager C, Bache M, Schmidt H and Taubert H . (2002). Lancet, 359, 943–945.

  • Xia C, Xu Z, Yuan X, Uematsu K, You L, Li K, Li L, McCormick F and Jablons DM . (2002). Mol. Cancer Ther., 1, 687–694.

  • Yagihashi A, Asanuma K, Nakamura M, Araya J, Mano Y, Torigoe T, Kobayashi D and Watanabe N . (2001). Clin. Chem., 47, 1729–1731.

  • Yamamoto T, Manome Y, Nakamura M and Tanigawa N . (2002). Eur. J. Cancer, 38, 2316–2324.

  • Yoshida H, Ishiko O, Sumi T, Matsumoto Y and Ogita S . (2001). Int. J. Oncol., 19, 537–542.

  • Yu D, Jing T, Liu B, Yao J, Tan M, McDonnell TJ and Hung M-C . (1998). Mol. Cell, 2, 581–591.

  • Zaffaroni N, Pennati M, Colella G, Perego P, Supino R, Gatti L, Pilotti S, Zunino F and Daidone MG . (2002). Cell. Mol. Life Sci., 59, 1406–1412.

  • Zhang JY, Casiano CA, Peng XX, Koziol JA, Chan EK and Tan EM . (2003). Cancer Epidemiol. Biomarkers Prev., 12, 136–143.

  • Zhang T, Otevrel T, Gao Z, Ehrlich SM, Fields JZ and Boman BM . (2001). Cancer Res., 61, 8664–8667.

  • Zhao J, Tenev T, Martins LM, Downward J and Lemoine NR . (2000). J. Cell Sci., 113, 4363–4371.

  • Zhou M, Gu L, Li F, Zhu Y, Woods WG and Findley HW . (2002). J. Pharmacol. Exp. Ther., 303, 124–131.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dario C Altieri.

Additional information

This work was supported by NIH Grants HL54131, CA78810 and CA90917

Rights and permissions

Reprints and permissions

About this article

Cite this article

Altieri, D. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 22, 8581–8589 (2003). https://doi.org/10.1038/sj.onc.1207113

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207113

Keywords

This article is cited by

Search

Quick links